Clinical Trial Update: Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the absolute bioavailability of Fer-In-Sol (ferrous sulfate) and Triferic (ferric pyrophosphate) when administered oral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron-refractory Iron-deficiency Anemia

Drugs mentioned

• Fer-In-Sol (ferrous sulfate)
• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Iron-refractory, Iron-deficiency Anemia (IRIDA) | Phase 1 | Status: COMPLETED | Results posted: 2019-02-01